Outcomes After Switching to BIC/FTC/TAF in Patients with Virological Failure to Protease Inhibitors or Non-Nucleoside Reverse Transcriptase Inhibitors: A Real-World Cohort Study

Chang HM, Chou PY, Chou CH, Tsai HC

Infection and Drug Resistance 2021, 14:4877-4886

Published Date: 23 November 2021